BR9603911A - Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas - Google Patents

Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas

Info

Publication number
BR9603911A
BR9603911A BR9603911A BR9603911A BR9603911A BR 9603911 A BR9603911 A BR 9603911A BR 9603911 A BR9603911 A BR 9603911A BR 9603911 A BR9603911 A BR 9603911A BR 9603911 A BR9603911 A BR 9603911A
Authority
BR
Brazil
Prior art keywords
medicine
benzoylguanidines
diagnosis
preparation
well
Prior art date
Application number
BR9603911A
Other languages
English (en)
Inventor
Udo Albus
Wolfgang Scholz
Jan-Robert Schwark
Andreas Weichert
Hans Jochen Lang
Heinz-Werner Kleemann
Joachim Brendel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9603911A publication Critical patent/BR9603911A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9603911A 1995-09-27 1996-09-26 Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas BR9603911A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95115240A EP0765867A1 (de) 1995-09-27 1995-09-27 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
BR9603911A true BR9603911A (pt) 1998-06-09

Family

ID=8219659

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9603911A BR9603911A (pt) 1995-09-27 1996-09-26 Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas

Country Status (20)

Country Link
US (1) US5747541A (pt)
EP (1) EP0765867A1 (pt)
JP (1) JPH09124584A (pt)
KR (1) KR970015568A (pt)
AR (1) AR004004A1 (pt)
AU (1) AU6584696A (pt)
BR (1) BR9603911A (pt)
CA (1) CA2186580A1 (pt)
CZ (1) CZ280896A3 (pt)
HR (1) HRP960430A2 (pt)
HU (1) HUP9602640A3 (pt)
IL (1) IL119293A0 (pt)
MX (1) MX9604338A (pt)
NO (1) NO964053L (pt)
NZ (1) NZ299445A (pt)
PL (1) PL315050A1 (pt)
SK (1) SK122596A3 (pt)
TR (1) TR199600753A1 (pt)
TW (1) TW339327B (pt)
ZA (1) ZA968091B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19859727A1 (de) * 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
WO2001045716A1 (en) * 1999-12-20 2001-06-28 Gho'st Holding B.V. Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor
US6410563B1 (en) 1999-12-22 2002-06-25 Merck Frosst Canada & Co. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
MY123585A (en) 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
US6639077B2 (en) 2000-03-23 2003-10-28 Merck Frosst Canada & Co. Tri-aryl-substituted-ethane PDE4 inhibitors
AU6196201A (en) 2000-05-25 2001-12-03 Merck Frosst Canada Inc Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
US6740666B2 (en) 2000-12-20 2004-05-25 Merck & Co., Inc. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
EP1397359B1 (en) 2001-05-24 2005-08-31 Merck Frosst Canada & Co. 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
JO2311B1 (en) 2001-08-29 2005-09-12 ميرك فروست كندا ليمتد Alkyl inhibitors Ariel phosphodiesterase-4
AU2003213783B2 (en) 2002-03-12 2007-01-25 Merck Sharp & Dohme Corp. Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
US7253218B2 (en) * 2004-03-01 2007-08-07 H.B. Fuller Company Sound damping compositions and methods for applying and baking same onto substrates
US20100035911A1 (en) * 2006-05-17 2010-02-11 Barry James Maurer Drug combinations to treat hyperproliferative disorders

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
ATE139526T1 (de) * 1992-02-15 1996-07-15 Hoechst Ag 3,5-substituierte benzoylguanidine, mit antiarrythmischer wirkung und inhibierender wirkung auf die proliferationen von zellen
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE59305042D1 (de) * 1992-09-22 1997-02-20 Hoechst Ag Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
TW250477B (pt) * 1992-12-15 1995-07-01 Hoechst Ag
TW250479B (pt) * 1992-12-15 1995-07-01 Hoechst Ag
DE59306029D1 (de) * 1992-12-16 1997-05-07 Hoechst Ag 3,5-Substituierte Aminobenzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
DK0612723T3 (da) * 1993-02-20 1998-03-30 Hoechst Ag Substituerede benzoylguanidiner, fremgangsmåde til fremstilling, deres anvendelse som lægemiddel, som inhibitor af den cellulære Na+/H+-udbytning eller som diagnostikum samt lægemiddel med indhold deraf
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5372607A (en) * 1993-06-23 1994-12-13 Medtronic, Inc. Method and apparatus for monitoring pacemaker intervals
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4327176C1 (de) * 1993-08-13 1995-01-26 Metallgesellschaft Ag Röhrenofen für die Erzeugung kohlenmonoxidhaltiger Gasgemische
DE4344550A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen
DE4402057A1 (de) * 1994-01-25 1995-08-03 Hoechst Ag Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4417004A1 (de) * 1994-05-13 1995-11-16 Hoechst Ag Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432106A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
DE4432101A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4441880A1 (de) * 1994-11-24 1996-05-30 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ATE185557T1 (de) * 1995-01-30 1999-10-15 Hoechst Ag Basisch-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament

Also Published As

Publication number Publication date
US5747541A (en) 1998-05-05
PL315050A1 (en) 1997-04-01
TW339327B (en) 1998-09-01
HRP960430A2 (en) 1998-02-28
SK122596A3 (en) 1997-05-07
IL119293A0 (en) 1996-12-05
NO964053L (no) 1997-04-01
HU9602640D0 (en) 1996-11-28
CZ280896A3 (en) 1997-06-11
CA2186580A1 (en) 1997-03-28
TR199600753A1 (tr) 1997-04-22
HUP9602640A2 (en) 1997-05-28
JPH09124584A (ja) 1997-05-13
NO964053D0 (no) 1996-09-26
HUP9602640A3 (en) 1997-11-28
AU6584696A (en) 1997-04-10
KR970015568A (ko) 1997-04-28
MX9604338A (es) 1997-03-29
ZA968091B (en) 1997-03-27
AR004004A1 (es) 1998-09-30
NZ299445A (en) 1997-11-24
EP0765867A1 (de) 1997-04-02

Similar Documents

Publication Publication Date Title
BR9605417A (pt) Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
BR9005093A (pt) Tampao,em especial para a higiene de senhoras,bem como processo e dispositivo para a fabricacao do mesmo
PT94956A (pt) Processo para a preparacao de azois com actividade pesticida
NO905431L (no) Trykkapplikator for medikament.
PT91864A (pt) Processo de preparacao de dieteres utilizaveis na preparacao de catalisadores de ziegler-natta
DE59007313D1 (de) Verbindungselement für die Osteosynthese.
DE69331228T4 (de) Heilmittel für thrombozytopenia
PT1222163E (pt) 1,1-bifenil-2-carboxamidas substituidas na posicao 2 processo para a sua preparacao, sua utilizacao como medicamento, bem como preparacoes farmaceuticas contendo estas
DE69610509T2 (de) Spezifizierende indexierungen für datenbanken
BR9603911A (pt) Benzoilguanidinas substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
DE9321547U1 (de) Spritze für medzinische Zwecke
BR9105406A (pt) Benzodiazepinonas,compostos,cetonas,processo para a preparacao de compostos,medicamento e uso
BR9602394A (pt) Guanididas de ácido alquenilcarboxílico processo para a sua preparação seus usos método para o tratamento de arritmias bem como medicamento
BR9703338A (pt) 2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm
DE69029546D1 (de) Ein Diagnosesystem
NO960364D0 (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
BR9600778A (pt) Benzenossulfoniluréia e - tiouréla substituida processo para sua preparação seu uso e medicamento
BR9703440A (pt) Benzoilguadinas orto-substituídas processos para sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo as mesmas
BR8403616A (pt) Artigo esterilizado e estabilizador por radiacao e processo para sua preparacao,artigo flexivel,processo para esterilizar e estabilizar por radiacao uma poliolefina
BR9703617A (pt) Benzoilguanidinas orto-substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo as mesmas
BR9605568A (pt) Benzoilguanidinas substituídas por sulfonilamino processo para a sua preparaçao seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
BR8907663A (pt) Processo para a desinfeccao de massas de moldagem medicas
BR8901036A (pt) Compostos,processo para sua preparacao,bem como sua aplicacao
BR9703342A (pt) 1-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm
BR9603112A (pt) Benzoilguanidinas processo para a sua preparação seu uso e medicamento

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law